Novel sequence-based mapping of recently emerging H5NX influenza viruses reveals pandemic vaccine candidates

PLoS ONE

Volumn 11, Issue 8, 2016, Pages

  Anderson, Christopher S ^a   DeDiego, Marta L ^a   Thakar, Juilee ^a   Topham, David J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS SIALIDASE; HEMAGGLUTININ, AVIAN INFLUENZA A VIRUS;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; AVIAN INFLUENZA VIRUS; AVIAN INFLUENZA VIRUS (H5NX); B LYMPHOCYTE; CLADISTICS; NONHUMAN; PHYLOGENETIC TREE; PROTEIN STRUCTURE; VIRUS STRAIN; GENETIC VARIATION; GENETICS; HUMAN; IMMUNOLOGY; INFLUENZA A VIRUS; ISOLATION AND PURIFICATION; PHYLOGENY;

AMINO ACID SUBSTITUTION; B-LYMPHOCYTES; EPITOPES; GENETIC VARIATION; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; PHYLOGENY;

EID: 84983089078     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0160510     Document Type: Article

References (41)

1. Verhagen JH, Herfst S, Fouchier R. How a virus travels the world. Science. 2015. doi: 10.1126/science.1259924
2. WHO. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003-2015. World Health Organization. 2015 May pp. 1-2.
3. Swayne DE, Suarez DL. Highly pathogenic avian influenza. Revue Scientifique Et Technique De L Office International Des Epizooties. 2000; 19: 463-482.
4. deJong JC, Claas E, Osterhaus A, Webster RG, Lim WL. A pandemic warning? Nature. 1997; 389: 554-554. doi: 10.1038/39218 PMID: 9335492
5. WHO. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness. 2015 Feb pp. 1-10. doi: 10.1111/irv.12230/full#irv12230
6. Claas E, Osterhaus A, Van Beek R, de Jong JC. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. The Lancet. 1998; 351: 472-477. doi: 10.1016/s0140-6736(97)11212-0
7. Subbarao K, Klimov A, Katz J, Regnery H, Lim W, Hall H, et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science. American Association for the Advancement of Science; 1998; 279: 393-396. doi: 10.1126/science.279.5349.393 PMID: 9430591
8. Saito T, Tanikawa T, Uchida Y, Takemae N, Kanehira K, Tsunekuni R. Intracontinental and intercontinental dissemination of Asian H5 highly pathogenic avian influenza virus (clade 2.3.4.4) in the winter of 2014-2015. Rev Med Virol. 2015;: n/a-n/a. doi: 10.1002/rmv.1857
9. de Vries E, Guo H, Dai M, Rottier PJM, van Kuppeveld FJM, de Haan CAM. Rapid Emergence of Highly Pathogenic Avian Influenza Subtypes from a Subtype H5N1 Hemagglutinin Variant. Emerg Infect Dis. 2015; 21: 842-846. doi: 10.3201/eid2105.141927 PMID: 25897518
10. Núñez A, Brookes SM, Reid SM, Garcia-Rueda C, Hicks DJ, Seekings JM, et al. Highly Pathogenic Avian Influenza H5N8 Clade 2.3.4.4 Virus: Equivocal Pathogenicity and Implications for Surveillance Following Natural Infection in Breeder Ducks in the United Kingdom. Transbound Emerg Dis. 2015;: n/a-n/a. doi: 10.1111/tbed.12442
11. USDA. Fall 2015 HPAI Preparedness and Response Plan. United States Department of Agriculture. 2015 Sep pp. 1-19.
12. Yang ZF, Mok C, Peiris J. Human Infection with a Novel Avian Influenza A (H5N6) Virus. New England Journal of .... 2015. doi: 10.1056/NEJMc1507438
13. de Vries E, Guo H, Dai M, Rottier PJM, van Kuppeveld FJM, de Haan CAM. Rapid Emergence of Highly Pathogenic Avian Influenza Subtypes from a Subtype H5N1 Hemagglutinin Variant. Emerging Infect Dis. 2015; 21: 842-846. doi: 10.3201/eid2105.141927 PMID: 25897518
14. Perelson AS, Oster GF. Theoretical studies of clonal selection: Minimal antibody repertoire size and reliability of self-non-self discrimination. Journal of Theoretical Biology. 1979; 81: 645-670. doi: 10.1016/0022-5193(79)90275-3 PMID: 94141
15. Smith DJ, Forrest S, Hightower RR, Perelson AS. Deriving shape space parameters from immunological data. Journal of Theoretical Biology. 1997; 189: 141-150. doi: 10.1006/jtbi.1997.0495 PMID: 9405131
16. Smith DJ, Lapedes AS, de Jong SC, Bestebroer TM, Rimmelzwaan GF, Osterhaus AD, et al. Mapping the Antigenic and Genetic Evolution of Influenza Virus. Science. 2004; 305: 371-376. doi: 10.1126/science.1097211 PMID: 15218094
17. Liu C-G, Liu M, Liu F, Lv R, Liu D-F, Qu L-D, et al. Emerging multiple reassortant H5N5 avian influenza viruses in ducks, China, 2008. Vet Microbiol. 2013; 167: 296-306. doi: 10.1016/j.vetmic.2013.09.004 PMID: 24080350
18. Bouwstra R, Heutink R, Bossers A, Harders F, Koch G, Elbers A. Full-Genome Sequence of Influenza A(H5N8) Virus in Poultry Linked to Sequences of Strains from Asia, the Netherlands, 2014. Emerg Infect Dis. 2015; 21: 872-874. doi: 10.3201/eid2105.141839 PMID: 25897965
19. Gu M, Liu W, Cao Y, Peng D, Wang X, Wan H, et al. Novel Reassortant Highly Pathogenic Avian Influenza (H5N5) Viruses in Domestic Ducks, China. Emerg Infect Dis. 2011; 17: 1060-1063. doi: 10.3201/eid1706.101406 PMID: 21749770
20. Underwood PA. Mapping of antigenic changes in the haemagglutinin of Hong Kong influenza (H3N2) strains using a large panel of monoclonal antibodies. Journal of General Virology. 1982; 62: 153-169. doi: 10.1099/0022-1317-62-1-153 PMID: 6182265
21. Koel BF, Burke DF, Bestebroer TM, van der Vliet S, Zondag GCM, Vervaet G, et al. Substitutions Near the Receptor Binding Site Determine Major Antigenic Change During Influenza Virus Evolution. Science. 2013; 342: 976-979. doi: 10.1126/science.1244730 PMID: 24264991
22. Kaverin NV, Rudneva IA, Govorkova EA, Timofeeva TA, Shilov AA, Kochergin-Nikitsky KS, et al. Epitope Mapping of the Hemagglutinin Molecule of a Highly Pathogenic H5N1 Influenza Virus by Using Monoclonal Antibodies. J Virol. 2007; 81: 12911-12917. doi: 10.1128/JVI.01522-07 PMID: 17881439
23. Kaverin NV, Rudneva IA, Govorkova EA, Timofeeva TA, Shilov AA, Kochergin-Nikitsky KS, et al. Epitope Mapping of the Hemagglutinin Molecule of a Highly Pathogenic H5N1 Influenza Virus by Using Monoclonal Antibodies. J Virol. 2007; 81: 12911-12917. doi: 10.1128/JVI.01522-07 PMID: 17881439
24. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness. Wkly Epidemiol Rec. 2015; 90: 561-571. doi: 10.1111/irv.12324/epdf PMID: 26477059
25. WHO, Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness. Wkly Epidemiol Rec. 2016; 91: 133-143. PMID: 26995804
26. Daly JM, Elton D. Potential of a sequence-based antigenic distance measure to indicate equine influenza vaccine strain efficacy. Vaccine. 2013; 31: 6043-6045. doi: 10.1016/j.vaccine.2013.06.070 PMID: 23831320
27. Cai Z, Zhang T, Wan X-F. Antigenic distance measurements for seasonal influenza vaccine selection. Vaccine. 2012; 30: 448-453. doi: 10.1016/j.vaccine.2011.10.051 PMID: 22063385
28. Liao YC, Lee MS, Ko CY, Hsiung CA. Bioinformatics models for predicting antigenic variants of influenza A/H3N2 virus. Bioinformatics. 2008; 24: 505-512. doi: 10.1093/bioinformatics/btm638 PMID: 18187440
29. Lees WD, Moss DS, Shepherd AJ. A computational analysis of the antigenic properties of haemagglutinin in influenza A H3N2. Bioinformatics. 2010; 26: 1403-1408. doi: 10.1093/bioinformatics/btq160 PMID: 20388627
30. Gupta V, Earl DJ, Deem MW. Quantifying influenza vaccine efficacy and antigenic distance. Vaccine. 2006; 24: 3881-3888. doi: 10.1016/j.vaccine.2006.01.010 PMID: 16460844
31. Lee MS, Chen J. Predicting antigenic variants of influenza A/H3N2 viruses. Emerg Infect Dis. 2004; 10: 1385-1390. doi: 10.3201/eid1008.040107 PMID: 15496238
32. Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, et al. Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine. 2008; 26: D31-D34. doi: 10.1016/j.vaccine.2008.07.078 PMID: 19230156
33. Kumari K, Gulati S, Smith DF, Gulati U, Cummings RD, Air GM. Receptor binding specificity of recent human H3N2 influenza viruses. Virology Journal. 2007; 4: 42-11. doi: 10.1186/1743-422X-4-42 PMID: 17490484
34. Chambers BS, Li Y, Hodinka RL, Hensley SE. Recent H3N2 influenza virus clinical isolates rapidly acquire hemagglutinin or neuraminidase mutations when propagated for antigenic analyses. J Virol. American Society for Microbiology; 2014; 88: 10986-10989. doi: 10.1128/JVI.01077-14 PMID: 24991002
35. Skowronski DM, Janjua NZ, De Serres G, Sabaiduc S, Eshaghi A, Dickinson JA, et al. Low 2012-13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses. Kobinger GP, editor. PLoS ONE. 2014; 9: e92153-15. doi: 10.1371/journal.pone.0092153 PMID: 24667168
36. Kilbourne ED. Influenza pandemics of the 20th century. Emerg Infect Dis. 2006; 12: 9-14. doi: 10.3201/eid1201.051254 PMID: 16494710
37. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, et al. Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans. Science. American Association for the Advancement of Science; 2009; 325: 197-201. doi: 10.1126/science.1176225 PMID: 19465683
38. Alam S, Knowlden ZAG, Sangster MY, Sant AJ. CD4 T cell help is limiting and selective during the primary B cell response to influenza virus infection. J Virol. American Society for Microbiology; 2014; 88: 314-324. doi: 10.1128/JVI.02077-13 PMID: 24155379
39. Kobayashi Y, Suzuki Y. Evidence for N-glycan shielding of antigenic sites during evolution of human influenza A virus hemagglutinin. J Virol. American Society for Microbiology; 2012; 86: 3446-3451. doi: 10.1128/JVI.06147-11 PMID: 22258255
40. GRANTHAM R. Amino-Acid Difference Formula to Help Explain Protein Evolution. Science. 1974; 185: 862-864. PMID: 4843792
41. Suzuki Y. Selecting vaccine strains for H3N2 human influenza A virus. MGENE. Elsevier B.V; 2015; 4: 64-72. doi: 10.1016/j.mgene.2015.03.003